These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 26291922)

  • 1. Staging the Axilla in Early Breast Cancer: Will Imaging Replace Surgery?
    Gentilini O; Veronesi U
    JAMA Oncol; 2015 Nov; 1(8):1031-2. PubMed ID: 26291922
    [No Abstract]   [Full Text] [Related]  

  • 2. [Sentinel node biopsy and axillary clearence in early breast cancer--An algorithm with explanations and queries].
    Cserni G
    Magy Seb; 2016 Mar; 69(1):4-13. PubMed ID: 26901689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sentinel lymph node biopsy in breast cancer: a comprehensive literature review.
    Salem A
    J Surg Educ; 2009; 66(5):267-75. PubMed ID: 20005499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How to handle positive sentinel nodes?
    Schmidt C
    J Natl Cancer Inst; 2010 Dec; 102(24):1820-1, 1823. PubMed ID: 21139099
    [No Abstract]   [Full Text] [Related]  

  • 5. A risk score model predictive of the presence of additional disease in the axilla in early-breast cancer patients with one or two metastatic sentinel lymph nodes.
    Canavese G; Bruzzi P; Catturich A; Vecchio C; Tomei D; Del Mastro L; Carli F; Guenzi M; Lacopo F; Dozin B
    Eur J Surg Oncol; 2014 Jul; 40(7):835-42. PubMed ID: 24684810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Five-node biopsy of the axilla: an alternative to axillary dissection of levels I-II in operable breast cancer.
    Ahlgren J; Holmberg L; Bergh J; Liljegren G
    Eur J Surg Oncol; 2002 Mar; 28(2):97-102. PubMed ID: 11884042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meta-analysis of predictive factors for non-sentinel lymph node metastases in breast cancer patients with a positive SLN.
    van la Parra RF; Peer PG; Ernst MF; Bosscha K
    Eur J Surg Oncol; 2011 Apr; 37(4):290-9. PubMed ID: 21316185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive factors of axillary lymph node metastasis in breast cancer.
    Wasuthit Y; Kongdan Y; Suvikapakornkul R; Lertsithichai P; Chirappapha P
    J Med Assoc Thai; 2011 Jan; 94(1):65-70. PubMed ID: 21425730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Sentinel lymph node biopsy after neoadjuvant chemotherapy in breast cancer].
    Mátrai Z; Tóth L; Polgár C; Láng I; Gõdény M; Sinkovics I; Horváth Z; Bidlek M; Udvarhelyi N; Bartal A; Sávolt A; Ujhelyi M; Kásler M
    Magy Onkol; 2011 Jun; 55(2):73-84. PubMed ID: 21655472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
    Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
    J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The evolution of lymph node assessment in breast cancer.
    Quan ML; McCready D
    J Surg Oncol; 2009 Mar; 99(4):194-8. PubMed ID: 19021226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Management of the axilla in breast cancer: evidences and unresolved issues].
    Fodor J; Polgár C; Péley G; Németh G
    Orv Hetil; 2001 Sep; 142(36):1941-50. PubMed ID: 11680099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Micrometastases in sentinel lymph nodes: few data make for hard decisions.
    Rowan K
    J Natl Cancer Inst; 2009 Oct; 101(20):1374-6. PubMed ID: 19797724
    [No Abstract]   [Full Text] [Related]  

  • 14. Is axillary dissection needed in node-positive breast cancer?
    Greenberg CC; Bafford AC; Golshan M
    Expert Rev Anticancer Ther; 2008 Feb; 8(2):195-8. PubMed ID: 18279060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expanding indications for lymphatic mapping and sentinel lymph node biopsy in the breast cancer population.
    Reintgen D
    Ann Surg Oncol; 2001 Oct; 8(9):687. PubMed ID: 11597007
    [No Abstract]   [Full Text] [Related]  

  • 16. Intraoperative sentinel node biopsy by one-step nucleic acid amplification (OSNA) avoids axillary lymphadenectomy in women with breast cancer treated with neoadjuvant chemotherapy.
    Navarro-Cecilia J; Dueñas-Rodríguez B; Luque-López C; Ramírez-Expósito MJ; Martínez-Ferrol J; Ruíz-Mateas A; Ureña C; Carrera-González MP; Mayas MD; Martínez-Martos JM
    Eur J Surg Oncol; 2013 Aug; 39(8):873-9. PubMed ID: 23711734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Frozen section exam value in breast cancer].
    Chifu C; Diaconu C
    Rev Med Chir Soc Med Nat Iasi; 2009; 113(3):771-9. PubMed ID: 20191831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A decade of sentinel lymph node biopsy for breast cancer: time for adaptations].
    Wobbes T
    Ned Tijdschr Geneeskd; 2008 Jan; 152(1):10-2. PubMed ID: 18240753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of sentinel lymph node biopsy in patients with a core biopsy diagnosis of ductal carcinoma in situ.
    Hung WK; Ying M; Chan M; Mak KL; Chan LK
    Breast Cancer; 2010 Oct; 17(4):276-80. PubMed ID: 19756924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgical management of the axilla: do intramammary nodes matter?
    Pugliese MS; Stempel MM; Cody HS; Morrow M; Gemignani ML
    Am J Surg; 2009 Oct; 198(4):532-7. PubMed ID: 19800463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.